PATENT CLAIM ANALYSIS

Application Number: 15779929
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["548", "435000"]

Abstract:
The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.

Claim (Index 8):
The norbornenone compound of  claim 1 , wherein A 1  and A 2  are each independently selected from halo, CN, NO 2 , S(O)R 9 , S(O) 2 R 9 , S(O) 2 OR 9 , SR 9 , NR 9 R 10 , C(\u2550O)R 9 , C(\u2550S)R 9 , C(\u2550CR 10 R 11 )R 9 , or A 1  and A 2  together form an optionally substituted monocyclic or polycyclic carbocyclyl or heterocyclyl; R 9  is selected from hydrogen, C 1-6 alkyl, C 1-6 haloalkyl, phenyl, phenylalkyl and phenylhaloalkyl; and R 10  and R 11  are each independently selected from hydrogen, C 1-4 alkyl, and C 1-4 haloalkyl.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.225
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11311731', '11338587', '12643641', '10561153', '11785998']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7720128342836168
- 35 USC 102 Novelty (BERT): 0.5287947719171184
- Combined Prediction Score: 0.747691028046967
- Mean Citation Score: 294.66267
- Max Citation Score: 354.02344
- Similarity Product: 237.7913832972145

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test